Meeder Asset Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,143
Closed -$129K 1504
2021
Q3
$129K Buy
3,143
+1,321
+73% +$72.4K 0.01% 833
2021
Q2
$103K Sell
1,822
-8
-0.4% -$295 ﹤0.01% 899
2021
Q1
$77K Buy
+1,830
New +$104K ﹤0.01% 977
2020
Q4
Sell
-6,091
Closed -$170K 1971
2020
Q3
$170K Buy
6,091
+6,086
+121,720% +$198K 0.01% 645
2020
Q2
$0 Sell
5
-648
-99% -$16.9K ﹤0.01% 2151
2020
Q1
$13K Buy
653
+65
+11% +$1.64K ﹤0.01% 1400
2019
Q4
$17K Buy
+588
New +$14.7K ﹤0.01% 1409
2019
Q3
Sell
-118
Closed -$3K 2166
2019
Q2
$3K Buy
+118
New +$2.82K ﹤0.01% 1786
2019
Q1
Sell
-571
Closed -$13K 1736
2018
Q4
$13K Buy
+571
New +$15.5K ﹤0.01% 1165
2018
Q3
Sell
-197
Closed -$7.06K 1586
2018
Q2
$7.06K Buy
197
+80
+68% +$2.83K ﹤0.01% 1192
2018
Q1
$4K Sell
117
-166
-59% -$5.92K ﹤0.01% 1271
2017
Q4
$8K Buy
+283
New +$7.13K ﹤0.01% 1184
2017
Q3
Sell
-128
Closed -$2K 1657
2017
Q2
$2K Sell
128
-59
-32% -$1.06K ﹤0.01% 1395
2017
Q1
$4K Sell
187
-271
-59% -$5.62K ﹤0.01% 1151
2016
Q4
$7K Buy
+458
New +$6.95K ﹤0.01% 809

Other funds holding EDIT

Meeder Asset Management's EDIT Position: Q4 2021 in Review

Meeder Asset Management sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 3,143 shares — an estimated $129K sold.

Meeder Asset Management first reported a position in EDIT in Q4 2016 and held it in 15 quarters. The position peaked at $170K in Q3 2020. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Meeder Asset Management reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 3,143 Editas Medicine shares in Q4 2021, an estimated $129K.
  • Meeder Asset Management first reported a position in Editas Medicine in Q4 2016 and held it in 15 quarters.
  • Meeder Asset Management's Editas Medicine position peaked at $170K in Q3 2020.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.